Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Sales Sector	48.93M	39.80M	39.46M	-	-
ALL Other Sectors	19.06K	23.46K	192.09K	191.08K	17.38K
Sales of Veterinary Medicines	-	-	-	2.23M	2.65M
Sales of Cleaning and Body Care Products and Foodstuffs	-	-	-	1.59M	3.88M
Sales of Human Medicines and Medical Supplies	-	-	-	42.13M	39.67M
Total	48.95M	39.82M	39.65M	46.14M	46.23M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Palestine	36.95M	28.46M	31.20M	-	-
Jordan	5.10M	4.33M	3.23M	-	-
Algeria	1.59M	1.22M	909.96K	-	-
Arabian Gulf	4.80M	5.43M	3.85M	-	-
Africa	298.97K	387.34K	456.12K	-	-
Europe	204.08K	-	-	-	-
Total	48.95M	39.82M	39.65M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error